bristol-myers glp-1 receptor agonist products Bristol Myers Squibb Frontiers | GLP-1 Receptor Agonists:
Description
Feng WH, Bi Y, Li P, Yin TT, Gao CX, Shen SM, et al
Current human studies have not shown an increased overall cancer risk with GLP-1 medications
Egbuna C, Chandra S, Awuchi CG, et al
Diabetes Care 46 , 384390 (2023)
Exendin-4 modulates diabetes onset in nonobese diabetic mice
137 Consequently, using multiple medications can result in DDIs, often leading to adverse drug reactions, making it crucial to assess the DDI potential
